Searched for
NOVO NORDISK WEGOVY PARTNERSHIP
How India and Japan are preparing for the AI economyIndia and Japan are forging a deep economic security partnership, moving beyond traditional aid and investment. The recent summit highlight...
From Pax Silica to Japan: Mapping India's AI Partnerships in 2026The first major global engagement in 2026 came in February, when India joined the Pax Silica initiative, a multilateral framework focussed ...
HCL Tech announces $1.14 billion AI partnership with European firmSources familiar with the matter told ET that the client is Mercedes-Benz, with HCLTech beating out Infosys, which was the incumbent vendor...
Microsoft launches firm to help companies adopt AI with $2.5 billionMicrosoft has launched a new venture, Microsoft Frontier Company, backed by $2.5 billion, to guide businesses in selecting and integrating ...
Medical device maker Zimmer Biomet to hire 500 employees in 3 years for tech centre in IndiaMedical device giant Zimmer Biomet is set to significantly expand its Indian footprint by hiring 500 professionals over three years for its...
Shantha Biologics to Make Injectable Drug Cartridges for Novo NordiskShantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable...
Tata Technologies expands partnership with Tenneco in $100 million dealTata Technologies and Tenneco LLC have inked a significant five-year deal exceeding $100 million to boost engineering and digital transform...
Zoho's Sridhar Vembu unveils new mission, nearly 6,000 km away from IndiaZoho founder Sridhar Vembu is embarking on a mission to connect rural Indian and Japanese businesses, aiming to revive traditional craftsma...
Uber, Waymo end robotaxi partnership in PhoenixUnder the partnership struck in 2023, Uber had integrated Waymo's autonomous vehicles into its ride-hailing and food delivery platforms.
BRICS CCI appoints Sharmishtha Ghosh as Executive Director for international partnershipsThe BRICS Chamber of Commerce and Industry has successfully appointed Sharmishtha Ghosh as the new Executive Director for International Par...
Netradyne announces partnership with GeosecureThe technology focuses on real-time intervention for risky behaviors and rewards safe driving, addressing critical issues like driver fatig...
Waaree Energies shares crash 5%. Can this US ruling dent solar panel maker's image for long?Waaree Energies shares fell nearly 5% after a US Customs ruling triggered concerns over reputational impact despite the company’s clarifica...
Big Four rethink partnership as AI changes the gameIndia's Big Four accounting firms, Deloitte, PwC, and EY, have surpassed 1,000 partners each, driven by rapid expansion, especially in tech...
India’s GLP-1 boom loses steam as price war, weak retention hit generic weight-loss drug salesInitial excitement for India's generic weight-loss drugs is fading. Domestic manufacturers are lowering sales targets due to slower-than-ex...
Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
Bombay HC cancels 'Duphachrit' trademark, rules it deceptively similar to Abbott's 'Dupha' familyThe Bombay High Court has cancelled Thane-based Menschlich Healthcare's trademark 'Duphachrit' in favour of Abbott Product Operations AG. T...
Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
UK approves Novo weight-loss pill to edge open European marketBritain's medicine regulator has approved Novo Nordisk's weight-loss pill. This makes the UK the first European market for the oral treatme...
Novo Nordisk hit by cyber incident, probes data breachDanish drugmaker Novo Nordisk has confirmed a security incident. Unauthorised access to internal IT systems occurred. Certain non-public da...
India’s anti-obesity drug market sees slower growth after initial surge in generic semaglutide salesIndia's anti-obesity drug market sees a slowdown after initial generic semaglutide sales. Demand has eased from its peak, with growth moder...